Simona Halep provisionally suspended after testing positive for banned substance
Simona Halep from France has been provisionally suspended by U.S. Anti-Doping Agency on Tuesday after testing positive for the anabolic steroid stanozolol.
The WTA player was provisionally suspended for 30 days on Tuesday after testing positive for a banned substance.
The agency said in a statement they would release the final decision of the suspension later in the day.
Halep was previously tested this month and found positive for stanozolol, a prohibited substance.
She tested positive on May 3 and received a provisional suspension of one year on July 26 after receiving a provisional suspension, which was later reduced to 30 days following clarification by the U.S. Anti-Doping Agency (DATA) from a French investigation.
Halep is not currently allowed to compete in the United States due to the 30-day suspension and the WTA said she will not be permitted to attend U.S. tournaments until she is fully cleared to play competitively.
While they did not rule out resuming the French star, they were not sure if she would still be able to compete at the highest level.
“Based on the recent test results, our professional advice is that Simona will not be able to compete at the 2016 U.S. Open nor the upcoming Grand Slams (French Open, Wimbledon and the U.S. Open),” said the WTA in a statement in May.
“Simona will require substantial time in recovery before being able to participate in those tournaments. We will have no further comment until that time.”
Despite her 30-day ban, Halep has not been ruled out of making a return to competition, as she is currently scheduled to compete in Paris on June 6 – a week on from her provisional suspension.
She was a finalist at the 2016 French Open and was ranked 20th at the time of the positive test. She lost in the first round of Roland Garros to American wildcard